Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL $61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical data sheet

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested

Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References

(PubMed link indicates BioLegend citation)
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  2. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  3. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  4. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  5. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  6. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  7. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  8. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  10. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  11. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  12. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  13. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  14. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  15. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  16. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  17. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  18. Rist M, et al. 2015. J Virol. 89:703. PubMed
  19. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  20. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  21. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  22. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  23. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  24. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  25. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  26. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  27. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  28. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  29. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  30. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  31. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  32. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  33. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  34. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  35. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  36. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  37. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  38. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  39. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  40. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  41. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  42. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  43. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  44. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  45. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  46. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  47. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  48. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  49. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  50. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  51. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  52. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  53. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  54. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  55. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  56. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  57. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  58. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  59. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  60. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  61. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  62. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  63. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  64. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  65. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  66. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  67. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  68. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  69. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  70. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  71. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  72. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  73. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  74. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  75. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  76. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  77. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  78. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  79. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  80. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  81. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  82. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  83. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  84. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  85. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  86. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  87. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  88. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  89. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  90. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  91. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  92. Guo C, et al. 2018. Immunity. 49:842. PubMed
  93. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  94. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  95. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  96. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  97. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  98. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  99. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  100. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  101. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  102. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  103. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  104. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  105. Sekine T, et al. 2020. Cell. 183:158. PubMed
  106. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  107. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  108. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  109. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  110. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  111. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  112. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  113. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  114. Markey K, et al. 2009. Blood. 113:5644. PubMed
  115. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  116. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  117. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  118. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  119. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  120. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  121. Harty N 2011. J Immunol. 186:3836. PubMed
  122. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  123. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account